356 related articles for article (PubMed ID: 12947691)
1. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
2. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow stem cells transplantation improve locomotive function of dystrophin/utrophin gene double knock-out mice].
Zhang C; Chen SL; Liu XR; Huang W; Zhang WX; Lu XL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):160-3. PubMed ID: 12905711
[TBL] [Abstract][Full Text] [Related]
4. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
5. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
Wang B; Li J; Fu FH; Xiao X
J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
[TBL] [Abstract][Full Text] [Related]
6. [Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells].
Li Z; Zhang C; Xie YM; Chen GJ; Liu XR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):294-7. PubMed ID: 15266833
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
Albesa M; Ogrodnik J; Rougier JS; Abriel H
Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
10. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
Rafael JA; Brown SC
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
13. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
[TBL] [Abstract][Full Text] [Related]
15. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
16. [Future treatment modalities in Duchenne muscular dystrophy].
Oron A; Shuper A; Shohat M
Harefuah; 1998 Apr; 134(7):557-60. PubMed ID: 10909603
[No Abstract] [Full Text] [Related]
17. Electromyographic studies in mdx and wild-type C57 mice.
Han JJ; Carter GT; Ra JJ; Abresch RT; Chamberlain JS; Robinson LR
Muscle Nerve; 2006 Feb; 33(2):208-14. PubMed ID: 16281275
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israƫl M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
19. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
20. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]